BackaBuddy COO Catherine Du Plooy interviewed on SABC NUUS for $2.3 Million drug for Baby Novah
Channel: BackaBuddy
Date: 2022-05-10

BackaBuddy COO,  Catherine Du Plooy speaks to SABC Nuus, (9/05/2022), about 7-month-old, Baby Novah De Wet, from Aggeneys, Northern Cape, who was diagnosed with Spinal Muscular Atrophy (SMA) type 1, a fatal, rare genetic disorder that affects important motor neurons in the body, responsible for movement and muscle development.

The condition which is the most common inherited fatal disease in infants can be treated with a miracle gene therapy drug, Zolgensma, available only in the US, which costs an astronomical R35 Million rand ($2.3 Million).

Read more: https://bit.ly/393KBfk
Donate: https://bit.ly/39QXfib